GOTOHomo sapiens (Human)Cancer cell line

🤖 AI SummaryBased on 7 publications

Quick Overview

Human neuroblastoma cell line with potential for cancer research.

Detailed Summary

The GOTO cell line is a human neuroblastoma cell line derived from a metastatic lymph node of a 2-year-old female child. It is used in cancer research for studying tumor characteristics and genetic alterations. This cell line has been identified in various studies for its role in understanding neuroblastoma biology and genetic mutations. Research on GOTO has contributed to the understanding of cancer cell behavior and potential therapeutic targets.
Generated on 6/16/2025

Basic Information

Database IDCVCL_1234
SpeciesHomo sapiens (Human)
Tissue SourceAdrenal gland[UBERON:UBERON_0002369]

Donor Information

Age1
Age CategoryPediatric
SexMale
Raceunknown

Disease Information

DiseaseNeuroblastoma
LineagePeripheral Nervous System
SubtypeNeuroblastoma
OncoTree CodeNBL

DepMap Information

Source TypeJCRB
Source IDACH-001716_source

Known Sequence Variations

TypeGene/ProteinDescriptionZygosityNoteSource
MutationSimpleNRASp.Gln61Leu (c.182A>T)Unspecified-PubMed=26214590

Haplotype Information (STR Profile)

Short Tandem Repeat (STR) profile for cell line authentication.

Amelogenin
X
CSF1PO
10,12
D13S317
15
D16S539
11,13
D18S51
14,15
D21S11
31,32,33
D3S1358
16,17
D5S818
11,12
D7S820
8,11
D8S1179
11,14
FGA
22
Penta D
9
Penta E
5,16
TH01
9
TPOX
11
vWA
17,18,19
Gene Expression Profile
Gene expression levels and statistical distribution
Loading cohorts...
Full DepMap dataset with combined data across cell lines

Loading gene expression data...

Publications

Pan-cancer proteomic map of 949 human cell lines.";

Robinson P.J., Zhong Q., Garnett M.J., Reddel R.R.

Cancer Cell 40:835-849.e8(2022).

An interactive resource to probe genetic diversity and estimated ancestry in cancer cell lines.

Dutil J., Chen Z.-H., Monteiro A.N.A., Teer J.K., Eschrich S.A.

Cancer Res. 79:1263-1273(2019).

A landscape of pharmacogenomic interactions in cancer.";

Wessels L.F.A., Saez-Rodriguez J., McDermott U., Garnett M.J.

Cell 166:740-754(2016).

A genome-wide screen for microdeletions reveals disruption of polarity complex genes in diverse human cancers.

Haber D.A.

Cancer Res. 70:2158-2164(2010).

Signatures of mutation and selection in the cancer genome.";

Deloukas P., Yang F.-T., Campbell P.J., Futreal P.A., Stratton M.R.

Nature 463:893-898(2010).

Oncogenic mutations of ALK kinase in neuroblastoma.";

Hayashi Y., Mano H., Ogawa S.

Nature 455:971-974(2008).

Identification of side population cells (stem-like cell population) in pediatric solid tumor cell lines.

Hayashi Y.

J. Pediatr. Surg. 42:2040-2045(2007).

PPM1D is a potential target for 17q gain in neuroblastoma.";

Sugimoto T., Inazawa J.

Cancer Res. 63:1876-1883(2003).

Screening the p53 status of human cell lines using a yeast functional assay.

Mizusawa H., Tanaka N., Koyama H., Namba M., Kanamaru R., Kuroki T.

Mol. Carcinog. 19:243-253(1997).

Establishment and characterization of a human neuroblastoma cell line in tissue culture.

Sekiguchi M., Oota T., Sakakibara K., Inui N., Fujii G.

Jpn. J. Exp. Med. 49:67-83(1979).

Differentiation of human neuroblastoma cells in vitro -- morphological changes induced by dibutyrl cyclic AMP.

Ishikawa S.

Acta Pathol. Jpn. 27:697-711(1977).

Tumor cell lines of the peripheral nervous system.";

Israel M.A., Thiele C.J.

(In book chapter) Atlas of human tumor cell lines; Hay R.J., Park J.-G., Gazdar A.F. (eds.); pp.43-78; Academic Press; New York; USA (1994).

Homogeneously staining regions and double minute chromosomes, prevalent cytogenetic abnormalities of human neuroblastoma cells.

Biedler J.L., Meyers M.B., Spengler B.A.

(In book chapter) Advances in cellular neurobiology, Vol. 4; Fedoroff S., Hertz L. (eds.); pp.267-307; Academic Press; New York; USA (1983).

Web Resources